Indication

For the control of serumphos phorus(sP) levels in adults with chronic kidney
disease (CKD) on hemodialysis or peritoneal dialysis,and for the control of sP
levels in paediatric patients 12 years of age and older with CKD stages 4-5
(defined as glomerular filtration rate < 30mL/min/1.73m² ) or CKD on dialysis.